Cargando…
Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib
Follicular lymphoma is predominantly managed as a chronic disease, with intermittent chemo/immunotherapy reserved for symptomatic progression. It is considered incurable with conventional treatments, and current therapeutic options are associated with significant toxicities that are especially limit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333814/ https://www.ncbi.nlm.nih.gov/pubmed/22536060 http://dx.doi.org/10.2147/PPA.S23241 |